NFKB1 and pancreatic neoplasm: In order to improve the efficiency of chemotherapeutic agents, a RNA aptamer against TfR was used to selectively deliver Dox and an inhibitor of NF-κB (decoy oligonucleotides) to pancreatic cancer cells.